Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Underrepresented faculty play a disproportionate role in advancing diversity and inclusion.

Jimenez MF, Laverty TM, Bombaci SP, Wilkins K, Bennett DE, Pejchar L.

Nat Ecol Evol. 2019 Jun 3. doi: 10.1038/s41559-019-0911-5. [Epub ahead of print]

PMID:
31160738
2.

cgMLST characterisation of invasive Neisseria meningitidis serogroup C and W strains associated with increasing disease incidence in the Republic of Ireland.

Mulhall RM, Bennett DE, Bratcher HB, Jolley KA, Bray JE, O'Lorcain PP, Cotter SM, Maiden MCJ, Cunney RJ.

PLoS One. 2019 May 29;14(5):e0216771. doi: 10.1371/journal.pone.0216771. eCollection 2019.

3.

Global state and potential scope of investments in watershed services for large cities.

Romulo CL, Posner S, Cousins S, Hoyle Fair J, Bennett DE, Huber-Stearns H, Richards RC, McDonald RI.

Nat Commun. 2018 Oct 22;9(1):4375. doi: 10.1038/s41467-018-06538-x.

4.

A retrospective assessment of the completeness and timeliness of meningococcal disease notifications in the Republic of Ireland over a 16-year period, 1999-2015.

O'Lorcain P, Bennett DE, Morgan SL, Cunney RJ, Cotter SM, Cafferkey MT, O'Flanagan DM.

Public Health. 2018 Mar;156:44-51. doi: 10.1016/j.puhe.2017.11.027. Epub 2018 Feb 3.

PMID:
29408188
5.

Clumping Factor B Promotes Adherence of Staphylococcus aureus to Corneocytes in Atopic Dermatitis.

Fleury OM, McAleer MA, Feuillie C, Formosa-Dague C, Sansevere E, Bennett DE, Towell AM, McLean WHI, Kezic S, Robinson DA, Fallon PG, Foster TJ, Dufrêne YF, Irvine AD, Geoghegan JA.

Infect Immun. 2017 May 23;85(6). pii: e00994-16. doi: 10.1128/IAI.00994-16. Print 2017 Jun.

6.

World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries.

Bertagnolio S, Penazzato M, Jordan MR, Persaud D, Mofenson LM, Bennett DE; Pediatric HIV ResNet Working Group.

Clin Infect Dis. 2012 May;54 Suppl 4:S254-60. doi: 10.1093/cid/cis003.

7.

A retrospective survey of HIV drug resistance among patients 1 year after initiation of antiretroviral therapy at 4 clinics in Malawi.

Wadonda-Kabondo N, Hedt BL, van Oosterhout JJ, Moyo K, Limbambala E, Bello G, Chilima B, Schouten E, Harries A, Massaquoi M, Porter C, Weigel R, Hosseinipour M, Aberle-Grasse J, Jordan MR, Kabuluzi S, Bennett DE.

Clin Infect Dis. 2012 May;54 Suppl 4:S355-61. doi: 10.1093/cid/cis004.

8.

Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods.

Bertagnolio S, Rodriguez-Diaz RA, Fuentes-Romero LL, Bennett DE, Viveros-Rogel M, Hart S, Pilon R, Sandstrom P, Soto-Ramirez LE.

Clin Infect Dis. 2012 May;54 Suppl 4:S328-33. doi: 10.1093/cid/cir938.

PMID:
22544198
9.

Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.

Dzangare J, Gonese E, Mugurungi O, Shamu T, Apollo T, Bennett DE, Kelley KF, Jordan MR, Chakanyuka C, Cham F, Banda RM.

Clin Infect Dis. 2012 May;54 Suppl 4:S313-6. doi: 10.1093/cid/cir1014.

10.

HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.

Bennett DE, Jordan MR, Bertagnolio S, Hong SY, Ravasi G, McMahon JH, Saadani A, Kelley KF.

Clin Infect Dis. 2012 May;54 Suppl 4:S280-9. doi: 10.1093/cid/cis207.

11.

Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004-2011.

Jordan MR, Bennett DE, Wainberg MA, Havlir D, Hammer S, Yang C, Morris L, Peeters M, Wensing AM, Parkin N, Nachega JB, Phillips A, De Luca A, Geng E, Calmy A, Raizes E, Sandstrom P, Archibald CP, Perriëns J, McClure CM, Hong SY, McMahon JH, Dedes N, Sutherland D, Bertagnolio S.

Clin Infect Dis. 2012 May;54 Suppl 4:S245-9. doi: 10.1093/cid/cis206.

12.

General dentists and periodontal referrals.

Bennett DE, Lee JH, Richards PS, Inglehart MR.

J Mich Dent Assoc. 2010 Sep;92(9):46-51.

PMID:
20945701
13.

Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.

Hong SY, Jonas A, Dumeni E, Badi A, Pereko D, Blom A, Muthiani VS, Shiningavamwe AN, Mukamba J, Andemichael G, Barbara R, Bennett DE, Jordan MR.

J Acquir Immune Defic Syndr. 2010 Dec;55(4):27-31. doi: 10.1097/QAI.0b013e3181f5376d.

14.

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, Heneine W, Kantor R, Jordan MR, Schapiro JM, Vandamme AM, Sandstrom P, Boucher CA, van de Vijver D, Rhee SY, Liu TF, Pillay D, Shafer RW.

PLoS One. 2009;4(3):e4724. doi: 10.1371/journal.pone.0004724. Epub 2009 Mar 6.

15.

Periodontal referral patterns of general dentists: lessons for dental education.

Lee JH, Bennett DE, Richards PS, Inglehart MR.

J Dent Educ. 2009 Feb;73(2):199-210.

16.

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy.

Johnson JA, Li JF, Wei X, Lipscomb J, Irlbeck D, Craig C, Smith A, Bennett DE, Monsour M, Sandstrom P, Lanier ER, Heneine W.

PLoS Med. 2008 Jul 29;5(7):e158. doi: 10.1371/journal.pmed.0050158.

17.

The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.

Bennett DE, Bertagnolio S, Sutherland D, Gilks CF.

Antivir Ther. 2008;13 Suppl 2:1-13.

PMID:
18578063
18.

HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.

Nguyen HT, Duc NB, Shrivastava R, Tran TH, Nguyen TA, Thang PH, McNicholl JM, Leelawiwat W, Chonwattana W, Sidibe K, Fujita M, Luu CM, Kakkar R, Bennett DE, Kaplan J, Cosimi L, Wolfe MI.

Antivir Ther. 2008;13 Suppl 2:115-21.

PMID:
18575200
19.

Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.

Pillay V, Ledwaba J, Hunt G, Rakgotho M, Singh B, Makubalo L, Bennett DE, Puren A, Morris L.

Antivir Ther. 2008;13 Suppl 2:101-7.

PMID:
18575198
20.

Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006.

Maphalala G, Okello V, Mndzebele S, Gwebu P, Mulima N, Dlamini S, Nhlabatsi B, Ginindza T, Ghebrenegus Y, Ntilivamunda A, Mwanyumba F, Ledwaba J, Pillay V, Bennett DE.

Antivir Ther. 2008;13 Suppl 2:95-100.

PMID:
18575197
21.

Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania.

Somi GR, Kibuka T, Diallo K, Tuhuma T, Bennett DE, Yang C, Kagoma C, Lyamuya EF, Swai RO, Kassim S.

Antivir Ther. 2008;13 Suppl 2:77-82.

PMID:
18575194
22.
24.

Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.

Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF.

Antivir Ther. 2008;13 Suppl 2:25-36.

PMID:
18575189
25.

World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.

Jordan MR, Bennett DE, Bertagnolio S, Gilks CF, Sutherland D.

Antivir Ther. 2008;13 Suppl 2:15-23.

PMID:
18575188
26.

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model.

Phillips AN, Pillay D, Miners AH, Bennett DE, Gilks CF, Lundgren JD.

Lancet. 2008 Apr 26;371(9622):1443-51. doi: 10.1016/S0140-6736(08)60624-8.

PMID:
18440426
27.

Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999-2000.

Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, McQuillan GM, Lewis B, Navin TR, Castro KG.

Am J Respir Crit Care Med. 2008 Feb 1;177(3):348-55. Epub 2007 Nov 7.

PMID:
17989346
28.

Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis.

Taha MK, Vázquez JA, Hong E, Bennett DE, Bertrand S, Bukovski S, Cafferkey MT, Carion F, Christensen JJ, Diggle M, Edwards G, Enríquez R, Fazio C, Frosch M, Heuberger S, Hoffmann S, Jolley KA, Kadlubowski M, Kechrid A, Kesanopoulos K, Kriz P, Lambertsen L, Levenet I, Musilek M, Paragi M, Saguer A, Skoczynska A, Stefanelli P, Thulin S, Tzanakaki G, Unemo M, Vogel U, Zarantonelli ML.

Antimicrob Agents Chemother. 2007 Aug;51(8):2784-92. Epub 2007 May 21.

29.
31.

PCR-based assay for detection of Neisseria meningitidis capsular serogroups 29E, X, and Z.

Bennett DE, Mulhall RM, Cafferkey MT.

J Clin Microbiol. 2004 Apr;42(4):1764-5.

32.
33.

Multilocus restriction typing: a tool for Neisseria meningitidis strain discrimination.

Bennett DE, Cafferkey MT.

J Med Microbiol. 2003 Sep;52(Pt 9):781-7.

PMID:
12909655
34.

DNA fingerprinting of Mycobacterium tuberculosis isolates from epidemiologically linked case pairs.

Bennett DE, Onorato IM, Ellis BA, Crawford JT, Schable B, Byers R, Kammerer JS, Braden CR.

Emerg Infect Dis. 2002 Nov;8(11):1224-9.

35.

Identifying the sources of tuberculosis in young children: a multistate investigation.

Sun SJ, Bennett DE, Flood J, Loeffler AM, Kammerer S, Ellis BA.

Emerg Infect Dis. 2002 Nov;8(11):1216-23.

36.
37.

Candidiasis: the emergence of a novel species, Candida dubliniensis.

Coleman DC, Sullivan DJ, Bennett DE, Moran GP, Barry HJ, Shanley DB.

AIDS. 1997 Apr;11(5):557-67. Review. No abstract available.

PMID:
9108936
38.

Effect of liposomal composition on photoactivated liposome fusion.

Miller CR, Bennett DE, Chang DY, O'Brien DF.

Biochemistry. 1996 Sep 10;35(36):11782-90.

PMID:
8794759
39.

Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species.

Sullivan DJ, Henman MC, Moran GP, O'Neill LC, Bennett DE, Shanley DB, Coleman DC.

J Med Microbiol. 1996 Jun;44(6):399-408. Review.

PMID:
8636956
40.

Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Sullivan DJ, Westerneng TJ, Haynes KA, Bennett DE, Coleman DC.

Microbiology. 1995 Jul;141 ( Pt 7):1507-21.

PMID:
7551019
41.

Photoactivated enhancement of liposome fusion.

Bennett DE, O'Brien DF.

Biochemistry. 1995 Mar 7;34(9):3102-13.

PMID:
7893722
42.

Oral Candida in HIV infection and AIDS: new perspectives/new approaches.

Coleman DC, Bennett DE, Sullivan DJ, Gallagher PJ, Henman MC, Shanley DB, Russell RJ.

Crit Rev Microbiol. 1993;19(2):61-82. Review.

PMID:
8338619
43.

Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation.

Gallagher PJ, Bennett DE, Henman MC, Russell RJ, Flint SR, Shanley DB, Coleman DC.

J Gen Microbiol. 1992 Sep;138(9):1901-11.

PMID:
1402791
44.

Infants born at risk: consequences for maternal post-partum adjustment.

Bennett DE, Slade P.

Br J Med Psychol. 1991 Jun;64 ( Pt 2):159-72.

PMID:
1883756
45.

Exact versus asymptotic analysis for a matched case-control study.

Hirji KF, Elashoff RM, Moore DH 2nd, Bennett DE.

Stat Med. 1988 Jul;7(7):765-72.

PMID:
3406604
46.

Dermatitis from plastic tote boxes impregnated with an antistatic agent.

Bennett DE, Mathias CG, Susten AS, Fannick NL, Smith AB.

J Occup Med. 1988 Mar;30(3):252-5.

PMID:
2966239
47.

Spectroscopic studies of the seven-iron-containing ferredoxins from Azotobacter vinelandii and Thermus thermophilus.

Johnson MK, Bennett DE, Fee JA, Sweeney WV.

Biochim Biophys Acta. 1987 Jan 5;911(1):81-94.

PMID:
3024733
48.

The electronic and magnetic properties of rubredoxin: a low-temperature magnetic circular dichroism study.

Bennett DE, Johnson MK.

Biochim Biophys Acta. 1987 Jan 5;911(1):71-80.

PMID:
3024732
50.

Supplemental Content

Loading ...
Support Center